Heart transplant have been performed since long at Fortis Group. And today our centres are internationally recognized benefitting patients with end-stage heart failure across the globe. We also focus on stabilization of patients as they await donor heart and alternative options for patients who are not candidates for transplant.
The indication for heart transplantation is stated as: ‘End-stage of heart disease not remediable by more conservative measures’.
Irreversible pulmonary hypertension/elevated pulmonary vascular resistance; active systemic infection; active malignancy or history of malignancy with probability of recurrence; inability to comply with complex medical regimen; severe peripheral or cerebrovascular disease and irreversible dysfunction of another organ, including diseases that may limit prognosis after heart transplantation.
Considering the difficulties in defining end-stage heart failure, estimating prognosis in the individual patient and the continuing evolution of available therapies, the present criteria are broadly defined. The final acceptance is done by the transplant team which has extensive knowledge of the treatment of patients with advanced heart failure on the one hand and thorough experience with heart transplantation and ECMO on the other hand.
Heart transplant may be considered as a viable option in many situations including heart valve abnormalities, congenital heart diseases and heart tumors; but irreversible heart muscle damage and cardiomyopathy being the two most common reasons for patients to undergo heart transplant.
As with any surgery, complications may occur during or post the surgery. Potential risks associated may include, but are not limited to, the following: Bleeding during or after the surgery, Kidney failure, Blood clots that lead to heart attack, stroke or lung problems, breathing problems. And sometimes the new heart may be rejected by the recipient’s immune system. To allow the transplanted heart to fit in a new body, immuno suppressants may be prescribed for life-long which may have certain side effects.
Pioneer in LVAD implant as permanent therapy in India, our doctors have a vast experience with VADs implant as a bridge to transplant and as a permanent support for patients who are not candidates for heart transplant.